PlainPharmaWatch

CMS Open Payments · Tool

Smisson-Cartledge Biomedical vs Mylan Technologies Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Payment Overview

Total Payments
$1.3M
% of Industry
0.0%
Transactions
16
Avg per Transaction
$81.3K
Recipients
0
Avg per Recipient
$0.00
Payment Types
0
Top Payment Type
-
Total Payments
$1.3M
% of Industry
0.0%
Transactions
43
Avg per Transaction
$29.9K
Recipients
0
Avg per Recipient
$0.00
Payment Types
0
Top Payment Type
-

Highlighted values indicate the higher figure for each metric.

Total payments compared

Smisson-Cartledge Biomedical vs Mylan Technologies Inc. - total reported payments in CMS Open Payments PY2024

Smisson-Cartledge Biomedical$1.3MMylan Technologies Inc.$1.3M

Summary Comparison

Metric Smisson-Cartledge Biomedical Mylan Technologies Inc.
Total Payments $1.3M $1.3M
% of Industry Total 0.0% 0.0%
Transaction Count 16 43
Avg per Transaction $81.3K $29.9K
Recipient Count 0 0
Avg per Recipient $0.00 $0.00
Payment Type Count 0 0
Top Payment Type - -

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.